Notice of Availability for the Patient Decontamination in a Mass Chemical Exposure Incident: National Planning Guidance for Communities, Correction, 1429 [2015-00200]
Download as PDF
rljohnson on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 6 / Friday, January 9, 2015 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5116,
MSC 7854, Bethesda, MD 20892, (301) 435–
1171, rosenl@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Basic Mechanisms of Cancer
Therapeutics Study Section.
Date: February 2–3, 2015.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Lambratu Rahman Sesay,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, 301–451–
3493, rahman-sesayl@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Behavioral Genetics and Epidemiology Study
Section.
Date: February 2, 2015.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 2620 Hotel Fisherman’s Wharf,
2620 Jones Street, San Francisco, CA 94133.
Contact Person: George Vogler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3140,
MSC 7770, Bethesda, MD 20892, (301) 237–
2693, voglergp@csr.nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Enabling Bioanalytical and
Imaging Technologies Study Section.
Date: February 4–5, 2015.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Arlington Capital
View Hotel, 2850 South Potomac Avenue,
Arlington, VA 22202.
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
MSC 7892, Bethesda, MD 20892, 301–435–
1047, dennis.hlasta@nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Molecular Pathobiology Study
Section.
Date: February 5–6, 2015.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin St. Francis, 335 Powell
Street, San Francisco, CA 94102.
Contact Person: Manzoor Zarger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, zargerma@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Clinical
and Integrative Diabetes and Obesity Study
Section.
VerDate Sep<11>2014
14:56 Jan 08, 2015
Jkt 235001
Date: February 5–6, 2015.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Nancy Sheard, SCD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046–E,
MSC 7892, Bethesda, MD 20892, 301–408–
9901, sheardn@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Biomedical
Imaging Technology A Study Section.
Date: February 5–6, 2015.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Serrano Hotel, 405 Taylor Street,
San Francisco, CA 94102.
Contact Person: Behrouz Shabestari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5126,
MSC 7854, Bethesda, MD 20892, (301) 435–
2409, shabestb@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Cellular and
Molecular Immunology—B Study Section.
Date: February 5–6, 2015.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Betty Hayden, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, 301–435–
1223, haydenb@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Language and Communication Study
Section.
Date: February 9, 2015.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Kabuki, 1625 Post Street, San
Francisco, CA 94115.
Contact Person: Andrea B Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 5, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–00120 Filed 1–8–15; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
1429
DEPARTMENT OF HOMELAND
SECURITY
Notice of Availability for the Patient
Decontamination in a Mass Chemical
Exposure Incident: National Planning
Guidance for Communities, Correction
Office of Health Affairs, DHS.
Notice of Availability.
AGENCY:
ACTION:
The Office of Health Affairs
published a document in the Federal
Register of December 19, 2014,
concerning the public release of a
guidance document, Patient
Decontamination in a Mass Chemical
Exposure Incident: National Planning
Guidance for Communities. The
document was missing a URL directing
readers to the electronic copy of the
document.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Dr.
Mark Kirk, Office of Health Affairs,
telephone (202) 254–6729.
Correction
In the Federal Register of December
19, 2014, in FR Vol. 79, No. 244, on
page 75826, in the third column, correct
the Web site to read:
The document is available on the following
Web sites: https://www.dhs.gov/office-healthaffairs and https://www.phe.gov/
Preparedness/responders/Pages/
patientdecon.aspx
Dated: January 5, 2015.
Mark Kirk,
Director, Chemical Defense Program.
[FR Doc. 2015–00200 Filed 1–8–15; 8:45 am]
BILLING CODE 9110–9K–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5828–N–02]
Federal Property Suitable as Facilities
To Assist the Homeless
Office of the Assistant
Secretary for Community Planning and
Development, HUD.
ACTION: Notice.
AGENCY:
This Notice identifies
unutilized, underutilized, excess, and
surplus Federal property reviewed by
HUD for suitability for possible use to
assist the homeless.
FOR FURTHER INFORMATION CONTACT:
Juanita Perry, Department of Housing
and Urban Development, 451 Seventh
Street SW., Room 7262, Washington, DC
20410; telephone (202) 402–3970; TTY
number for the hearing- and speechimpaired (202) 708–2565, (these
telephone numbers are not toll-free), or
SUMMARY:
E:\FR\FM\09JAN1.SGM
09JAN1
Agencies
[Federal Register Volume 80, Number 6 (Friday, January 9, 2015)]
[Notices]
[Page 1429]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00200]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HOMELAND SECURITY
Notice of Availability for the Patient Decontamination in a Mass
Chemical Exposure Incident: National Planning Guidance for Communities,
Correction
AGENCY: Office of Health Affairs, DHS.
ACTION: Notice of Availability.
-----------------------------------------------------------------------
SUMMARY: The Office of Health Affairs published a document in the
Federal Register of December 19, 2014, concerning the public release of
a guidance document, Patient Decontamination in a Mass Chemical
Exposure Incident: National Planning Guidance for Communities. The
document was missing a URL directing readers to the electronic copy of
the document.
FOR FURTHER INFORMATION CONTACT: Dr. Mark Kirk, Office of Health
Affairs, telephone (202) 254-6729.
Correction
In the Federal Register of December 19, 2014, in FR Vol. 79, No.
244, on page 75826, in the third column, correct the Web site to read:
The document is available on the following Web sites: https://www.dhs.gov/office-health-affairs and https://www.phe.gov/Preparedness/responders/Pages/patientdecon.aspx
Dated: January 5, 2015.
Mark Kirk,
Director, Chemical Defense Program.
[FR Doc. 2015-00200 Filed 1-8-15; 8:45 am]
BILLING CODE 9110-9K-P